• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2009 NIHR Horizon Scanning Centre (NIHR HSC) Cediranib (Recentin) for recurrent glioblastoma multiforme - second or third line
2009 NIHR Horizon Scanning Centre (NIHR HSC) Cediranib (Recentin) with XELOX or FOLFOX for advanced metastatic colorectal cancer - first line
2009 NIHR Horizon Scanning Centre (NIHR HSC) Ataluren for nonsense mutation dystrophinopathy
2009 NIHR Horizon Scanning Centre (NIHR HSC) Albinterferon alfa-2b (Joulferon) for hepatitis C with compensated liver disease
2009 NIHR Horizon Scanning Centre (NIHR HSC) Aflibercept (VEGF-Trap) for locally advanced or metastatic non-small cell lung cancer - second line
2009 NIHR Horizon Scanning Centre (NIHR HSC) AEGR-733 (Lomitapide) for hypercholesterolaemia
2009 NIHR Horizon Scanning Centre (NIHR HSC) Aflibercept (VEGF-Trap) for metastatic colorectal cancer - second line
2009 NIHR Horizon Scanning Centre (NIHR HSC) Cabazitaxel (XRP-6258) for hormone refractory, metastatic prostate cancer - second line after docetaxel
2009 NIHR Horizon Scanning Centre (NIHR HSC) Neurology monitoring (Entropy) for depth of anaesthesia
2009 NIHR Horizon Scanning Centre (NIHR HSC) Eplivanserin for chronic insomnia characterised by difficulties with sleep maintenance
2009 NIHR Horizon Scanning Centre (NIHR HSC) Eribulin for locally advanced or metastatic breast cancer - third line; monotherapy
2009 NIHR Horizon Scanning Centre (NIHR HSC) Indacaterol (Onbrez Breezhaler) for chronic obstructive pulmonary disease
2009 NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab for follicular non-Hodgkin's lymphoma - refractory
2009 NIHR Horizon Scanning Centre (NIHR HSC) Patupilone (EPO906) for recurrent epithelial ovarian cancer - refractory and/or resistant
2009 NIHR Horizon Scanning Centre (NIHR HSC) Pirfenidone for idiopathic pulmonary fibrosis
2009 NIHR Horizon Scanning Centre (NIHR HSC) Quetiapine (Seroquel XL) for major depressive disorder
2009 NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for macular oedema secondary to central or branch retinal vein occlusion
2009 NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for diabetic macular oedema
2009 NIHR Horizon Scanning Centre (NIHR HSC) Retigabine for partial onset epilepsy - refractory
2009 NIHR Horizon Scanning Centre (NIHR HSC) Sativex for adults experiencing pain from cancer
2009 NIHR Horizon Scanning Centre (NIHR HSC) Vinflunine (Javlor) for transitional cell carcinoma of the urothelial tract - second line
2009 NIHR Horizon Scanning Centre (NIHR HSC) Afamelanotide for erythropoietic protoporphyria and congenital erythropoietic porphyria
2009 NIHR Horizon Scanning Centre (NIHR HSC) Alipogene tiparvovec (AMT-011, Glybera) for lipoprotein lipase deficiency
2009 NIHR Horizon Scanning Centre (NIHR HSC) Clopidogrel (Plavix) for neonates and infants with cyanotic congenital heart disease who have undergone a palliative shunt procedure
2009 NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab for fludarabine-refractory chronic lymphocytic leukaemia - second or third-line
2009 NIHR Horizon Scanning Centre (NIHR HSC) Omalizumab (Xolair) for severe persistent allergic asthma in children
2009 NIHR Horizon Scanning Centre (NIHR HSC) Silodosin for benign prostatic hyperplasia
2009 NIHR Horizon Scanning Centre (NIHR HSC) WATCHMAN left atrial appendage (LAA) closure device for non-valvular atrial fibrillation (AF)
2009 NIHR Horizon Scanning Centre (NIHR HSC) Agento I.C for ventilator associated pneumonia
2009 NIHR Horizon Scanning Centre (NIHR HSC) Radachlorin photodynamic therapy for basal cell carcinoma
2009 The Swedish Council on Health Technology Assessment (SBU) [Computerized training for children with ADHD]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Age-related macular degeneration: the role of current treatment strategies]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Amotosalen (Intercept) for the inactivation of pathogens for transfusion therapy]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Angiographic profile of patients undergoing drug eluting stent implantation in Spain. Variability of off-label indications]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Artificial liver support systems]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [AUDIT ONCOrisk: Quality of the information in the study about digestive oncological surgery results]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Comparison of the effectiveness of slow-release dosage forms (depot) versus oral dosage forms of antipsychotics (typical and atypical), marketed in Catalonia, in patients with a diagnosis of schizophrenia]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Defibrillators in public places]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Development of a shared knowledge system for network assessment of technological innovation in medicine]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Eculizumab for the treatment of paroxysmal nocturnal haemoglobinuria]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Effectiveness of the filum terminale section for the treatment of Chiari I malformation]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Hadrontherapy in the treatment of cancer]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Health and health services use in immigrant and native population in Spain]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Impact of clinical and health services research in advancing knowledge. Applied study to the CAHTA research calls]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Implementation and development of a treatment programme for peritoneal carcinomatosis in Catalonia. Indications and clinical results using Sugarbaker's technique]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Influence of an existing health care plan aimed at managing ST-elevation myocardial infarction on the waiting time until re-perfusion, and types of re-perfusion. Pilot study]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Lower respiratory tract infections of a viral origin in the paediatric population: systematic review of Spanish literature]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Miglustat (Zavesca) in the treatment of Niemann-Pick type C disease]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Overweight in the teenager population: quality of life, access to health care services and cost-effectiveness of interventions]
2009 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Trabectedin (Yondelis) in the treatment of soft tissue sarcomas]
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Indirect evidence: indirect treatment comparisons in meta-analysis
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Portable ultrasonography in small emergency departments: a systematic review of the guidelines and clinical-effectiveness
2009 Adelaide Health Technology Assessment (AHTA) A toolkit for the identification and assessment of new and emerging health technologies
2009 Adelaide Health Technology Assessment (AHTA) Cervista HPV 16/18 for the identification of strains of the human papillomavirus associated with cervical cancer
2009 Adelaide Health Technology Assessment (AHTA) New and emerging technologies for breast cancer detection
2009 Adelaide Health Technology Assessment (AHTA) Rapid testing and targeted population screening for Helicobacter pylori
2009 Adelaide Health Technology Assessment (AHTA) Internet delivered cognitive behavioural therapy for patients with depression
2009 Adelaide Health Technology Assessment (AHTA) Rapid urine test for Chlamydia trachomatis
2009 Adelaide Health Technology Assessment (AHTA) Wearable artificial kidney (WAK): Portable dialysis for patients with chronic kidney disease
2009 Adelaide Health Technology Assessment (AHTA) LifePort kidney transporter: Portable donor kidney transporter/ perfuser
2009 Adelaide Health Technology Assessment (AHTA) NMP22 BladderChek Diagnostic test for bladder cancer: update
2009 Adelaide Health Technology Assessment (AHTA) TomoTherapy HI-ART System radiotherapy planning and treatment for cancer
2009 Adelaide Health Technology Assessment (AHTA) Non-invasive prenatal diagnostic test for trisomy-21 (Down's Syndrome)
2009 Adelaide Health Technology Assessment (AHTA) 0.2-0.5 Tesla MRi for the detection of arthritis and musculoskeletal disease
2009 Adelaide Health Technology Assessment (AHTA) Breast tomosynthesis: a breast cancer screening tool
2009 Adelaide Health Technology Assessment (AHTA) Narrow Band Imaging for the improved detection of precancerous lesions during colonoscopy
2009 Adelaide Health Technology Assessment (AHTA) MRI for diagnosis of rheumatoid arthritis
2009 Adelaide Health Technology Assessment (AHTA) Hypertonic saline therapy for cystic fibrosis
2009 Adelaide Health Technology Assessment (AHTA) Continuous glucose monitoring in pregnant women with diabetes
2009 Adelaide Health Technology Assessment (AHTA) LIPOchip DNA microarray for the detection of familial hypercholesterolaemia
2009 Adelaide Health Technology Assessment (AHTA) T-Stat system for the detection of tissue ischemia
2009 Andalusian Health Technology Assessment Area (AETSA) [Development of criteria, complexity indicators and management strategies on frailty]
2009 Health Intervention and Technology Assessment Program (HITAP) The Thai population based preference scores for EQ5D health states
2009 Health Intervention and Technology Assessment Program (HITAP) Assessing the implication of Thailand's government use licenses issued in 2006-2008
2009 Health Intervention and Technology Assessment Program (HITAP) The potential of provider-initiated voluntary HIV counseling and testing at health care settings in Thailand
2009 Andalusian Health Technology Assessment Area (AETSA) [Effectiveness of two therapeutic options in the treatment of peripheral vascular disease: sympathectomy and spinal cord stimulation]
2009 Andalusian Health Technology Assessment Area (AETSA) [Appropriateness criteria for vertebral arthrodesis]
2009 Andalusian Health Technology Assessment Area (AETSA) [Endovascular treatment of cerebrovascular disease]
2009 Andalusian Health Technology Assessment Area (AETSA) [Diagnostic performance of digital mammography in breast cancer screening]
2009 Andalusian Health Technology Assessment Area (AETSA) [Appropriate use of recombinant activated factor VII in nonhaemophilic patients]
2009 Penn Medicine Center for Evidence-based Practice (CEP) Early term induction of labor
2009 HAYES, Inc. Breast-specific gamma imaging (BSGI)
2009 HAYES, Inc. AlloDerm regenerative tissue matrix (LifeCell Corp.) for postmastectomy breast reconstruction
2009 HAYES, Inc. Hippotherapy for Neuromusculoskeletal Dysfunction
2009 HAYES, Inc. Continuous renal replacement therapy (CRRT) versus sustained low-efficiency daily dialysis (SLED) for adults with non-trauma-related acute renal failure
2009 HAYES, Inc. Continuous rotation of patients with acute respiratory distress syndrome (ARDS)
2009 HAYES, Inc. Continuous subglottic secretion removal from the Hi-Lo endotracheal tube (Nellcor Puritan Bennett LLC) for prevention of ventilator-associated pneumonia (VAP)
2009 HAYES, Inc. Impella recover LP 2.5 percutaneous ventricular assist device (Abiomed Inc.)
2009 HAYES, Inc. Intravascular ultrasound (IVUS) for the assessment of peripheral artery disease (PAD) of the lower extremities
2009 HAYES, Inc. Natalizumab (Tysabri, Biogen Idec and Elan Pharmaceuticals) for relapsing remitting multiple sclerosis
2009 HAYES, Inc. Percutaneous sacroplasty for treatment of sacral insufficiency fractures
2009 HAYES, Inc. Prehospital/emergency department therapeutic hypothermia for out-of-hospital cardiac arrest (OHCA) in adults
2009 HAYES, Inc. Robotically assisted nephrectomy for renal malignancy using the da Vinci surgical system (Intuitive Surgical Inc.) for adult patients
2009 HAYES, Inc. Synvisc (hylan G-F 20) (Genzyme Corp.) for arthritis of the ankle
2009 HAYES, Inc. Trellis-8 Peripheral Infusion System (Bacchus Vascular Inc.) for deep vein thrombosis
2009 HAYES, Inc. Acupuncture for treatment of headache
2009 HAYES, Inc. Acupuncture for treatment of postoperative pain
2009 HAYES, Inc. Antimicrobial central venous catheters
2009 HAYES, Inc. Combined positron emission tomography-computed tomography (PET-CT) for lung
2009 HAYES, Inc. Computer-assisted cognitive-behavioral treatment for depression